Pages that link to "Q28362976"
Jump to navigation
Jump to search
The following pages link to Development and characterization of novel erythropoiesis stimulating protein (NESP) (Q28362976):
Displaying 50 items.
- Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants (Q24195000) (← links)
- Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease (Q24202919) (← links)
- Structural and biophysical studies of the human IL-7/IL-7Ralpha complex (Q24641959) (← links)
- Immunogenicity of Biotherapeutics: Causes and Association with Posttranslational Modifications (Q26738810) (← links)
- Acceptable changes in quality attributes of glycosylated biopharmaceuticals (Q28235143) (← links)
- Ubiquitous Importance of Protein Glycosylation (Q30394129) (← links)
- Capillary electrophoresis and matrix-assisted laser desorption/ionization-time of flight-mass spectrometry for analysis of the novel erythropoiesis-stimulating protein (NESP). (Q33212718) (← links)
- Evaluation of epoetin alpha (rHuEPO) and darbepoetin alpha (DARB) on human burst-colony formation (BFU-E) in culture (Q33239436) (← links)
- Novel strategies for stimulating erythropoiesis and potential new treatments for anaemia (Q33256941) (← links)
- Current and future use of hematopoietic growth factors in cancer medicine (Q33367026) (← links)
- Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity (Q33420853) (← links)
- Dynamic fluctuations of protein-carbohydrate interactions promote protein aggregation (Q33520919) (← links)
- Methods of solving rapid binding target-mediated drug disposition model for two drugs competing for the same receptor (Q33655344) (← links)
- Production of complex multiantennary N-glycans in Nicotiana benthamiana plants. (Q33793024) (← links)
- Sialic acid linkage differentiation of glycopeptides using capillary electrophoresis - electrospray ionization - mass spectrometry (Q33807752) (← links)
- The effect of erythropoietin on the severity of retinopathy of prematurity (Q33891194) (← links)
- Darbepoetin alfa (Aranesp) (Q34116738) (← links)
- Enhancement of therapeutic protein in vivo activities through glycoengineering (Q34180647) (← links)
- Darbepoetin alfa (Q34458499) (← links)
- Analytical platform for glycomic characterization of recombinant erythropoietin biotherapeutics and biosimilars by MS. (Q34593205) (← links)
- Erythropoietin after a century of research: younger than ever (Q34606348) (← links)
- Darbepoetin alfa: a novel erythropoiesis-stimulating protein (Q34709820) (← links)
- Protein therapeutics: a summary and pharmacological classification (Q34728463) (← links)
- Managing anemia in patients with chronic kidney disease or cancer: development and role of darbepoetin alfa (Q34834784) (← links)
- An overview of the pharmacokinetic disposition of darbepoetin alfa (Q34834816) (← links)
- Overview of cancer-related anemia: focus on the potential role of darbepoetin alfa (Q34834866) (← links)
- Dose conversion from recombinant human erythropoietin to darbepoetin alfa: recommendations from clinical studies (Q34834889) (← links)
- Darbepoetin alfa: a review of its use in patients with cancer (Q34983303) (← links)
- The enigma of the metabolic fate of circulating erythropoietin (Epo) in view of the pharmacokinetics of the recombinant drugs rhEpo and NESP. (Q35013346) (← links)
- Optimization of protein therapeutics by directed evolution (Q35060233) (← links)
- Planning for hemorrhage. Steps an anesthesiologist can take to limit and treat hemorrhage in the obstetric patient (Q35108523) (← links)
- Myeloma: Update on supportive care strategies (Q35116240) (← links)
- Design of homogeneous, monopegylated erythropoietin analogs with preserved in vitro bioactivity (Q35126977) (← links)
- Darbepoetin alfa: in patients with chemotherapy-related anaemia (Q35128635) (← links)
- Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies. (Q35202899) (← links)
- Functional EpoR pathway utilization is not detected in primary tumor cells isolated from human breast, non-small cell lung, colorectal, and ovarian tumor tissues (Q35217404) (← links)
- A simple MALDI plate functionalization by Vmh2 hydrophobin for serial multi-enzymatic protein digestions (Q35419713) (← links)
- Anemia in Lung Cancer: Clinical Impact and Management (Q35575032) (← links)
- The development of supportive-care agents for patients with cancer (Q35598495) (← links)
- A multicenter retrospective cohort study of practice patterns and clinical outcomes of the use of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia (Q35615242) (← links)
- Differentiating factors between erythropoiesis-stimulating agents: a guide to selection for anaemia of chronic kidney disease (Q35672484) (← links)
- Preclinical safety testing of biotechnology-derived pharmaceuticals: understanding the issues and addressing the challenges (Q35762295) (← links)
- Attenuation of inflammation and apoptosis by pre- and posttreatment of darbepoetin-alpha in acute liver failure of mice (Q35855561) (← links)
- Glycomics: a pathway to a class of new and improved therapeutics (Q35906116) (← links)
- Cognitive outcomes of preterm infants randomized to darbepoetin, erythropoietin, or placebo (Q35935811) (← links)
- Strategies to optimize the use of erythropoietin and iron therapy in oncology patients (Q35976513) (← links)
- From EPOthilone to EPO: Aa challenge for natural product synthesis (Q35982725) (← links)
- Probing the stability of nonglycosylated wild-type erythropoietin protein via reiterative alanine ligations (Q35982743) (← links)
- Management of cancer anemia (Q36028737) (← links)
- Once-weekly treatment of anemia in patients with cancer: a comparative review of epoetins (Q36193223) (← links)